We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
-1.5%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$11.3B
AUM Growth
+$2.15B
(+23%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
26.6%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
2,593
New
888
Increased
644
Reduced
565
Closed
479
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$887M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$812M |
| 3 |
Microsoft
MSFT
|
+$670M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$516M |
| 5 |
NVIDIA
NVDA
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTKI
First Trust Small Cap BuyWrite Income ETF
FTKI
|
+$452M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$147M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$135M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$112M |
| 5 |
Walmart Inc
WMT
|
+$89.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.8% |
| 2 | Consumer Discretionary | 10.24% |
| 3 | Financials | 7.64% |
| 4 | Industrials | 5.46% |
| 5 | Communication Services | 3.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Community Health Systems
CYH
$393M
| $66K | ﹤0.01% |
22,440
-27,934
| -55% | -$90.5K |
|
2052
AbCellera Biologics
ABCL
$1.62B
| $65.7K | ﹤0.01% |
+18,824
| New | +$67.7K |
|
2053
Palladyne AI
PDYN
$239M
| $65.7K | ﹤0.01% |
+10,817
| New | +$73.3K |
|
2054
indie Semiconductor
INDI
$678M
| $64.6K | ﹤0.01% |
20,065
+1,849
| +10% | +$6.53K |
|
2055
CALL
CAMP4 Therapeutics
CAMP
$178M
| $64.4K | ﹤0.01% |
+14,608
| New | +$69.3K |
|
2056
Stoneridge
SRI
$208M
| $63.5K | ﹤0.01% |
+13,138
| New | +$90.1K |
|
2057
Satellogic
SATL
$523M
| $62.3K | ﹤0.01% |
11,457
-63,052
| -85% | -$232K |
|
|
SRTA
2058
Strata Critical Medical Inc
SRTA
$440M
| $60.4K | ﹤0.01% |
+14,461
| New | +$69.6K |
|
|
VENU
2059
PUT
Venu Holding Corp
VENU
$133M
| $58.2K | ﹤0.01% |
+17,571
| New | +$101K |
|
2060
Candel Therapeutics
CADL
$709M
| $57.9K | ﹤0.01% |
+11,821
| New | +$64.3K |
|
2061
Geron
GERN
$930M
| $57.8K | ﹤0.01% |
38,823
-5,790
| -13% | -$8.8K |
|
2062
CALL
Veritone
VERI
$96.7M
| $57.5K | ﹤0.01% |
+29,213
| New | +$98.8K |
|
2063
Petco
WOOF
$811M
| $57.4K | ﹤0.01% |
20,656
-22,120
| -52% | -$61.2K |
|
2064
Compass Therapeutics
CMPX
$367M
| $54K | ﹤0.01% |
10,200
-108,328
| -91% | -$625K |
|
2065
GoodRx Holdings
GDRX
$1.06B
| $53.4K | ﹤0.01% |
27,233
-220,856
| -89% | -$518K |
|
2066
CALL
Context Therapeutics
CNTX
$54.3M
| $53K | ﹤0.01% |
+20,220
| New | +$47.2K |
|
2067
Opko Health
OPK
$1.23B
| $52.3K | ﹤0.01% |
45,919
-39,429
| -46% | -$48.5K |
|
2068
Ranpak Holdings
PACK
$550M
| $52.2K | ﹤0.01% |
+14,616
| New | +$71.9K |
|
2069
Comtech Telecommunications
CMTL
$51.5M
| $52K | ﹤0.01% |
+15,655
| New | +$80.5K |
|
2070
Bit Digital
BTBT
$459M
| $51.8K | ﹤0.01% |
+39,557
| New | +$72.6K |
|
2071
Immunic
IMUX
$182M
| $50.9K | ﹤0.01% |
+4,584
| New | +$41.1K |
|
2072
Ironwood Pharmaceuticals
IRWD
$626M
| $49.9K | ﹤0.01% |
+14,218
| New | +$58.3K |
|
2073
Backblaze
BLZE
$724M
| $49.6K | ﹤0.01% |
+14,378
| New | +$60.5K |
|
2074
Cerus
CERS
$585M
| $48.9K | ﹤0.01% |
+26,877
| New | +$58.6K |
|
|
CMRC
2075
Commerce.com Inc Series 1
CMRC
$264M
| $46.9K | ﹤0.01% |
17,571
-2,509
| -12% | -$7.8K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
GIM
DWM
MIFH
Brevan Howard Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Brevan Howard Capital Management held 2,593 positions worth $11.3B, up 23% from $9.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Brevan Howard Capital Management deployed $3.01B of net new capital in Q1 2026, opening 888 new positions and adding to 644 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $147M trimmed.
- Brevan Howard Capital Management's largest Q1 2026 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.
- Brevan Howard Capital Management added most to Invesco QQQ Trust in Q1 2026, an estimated $887M increase.
- Brevan Howard Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class A, cutting an estimated $147M.
- Brevan Howard Capital Management fully exited First Trust Small Cap BuyWrite Income ETF in Q1 2026, selling an estimated $452M.
- Brevan Howard Capital Management's ten largest holdings make up 40% of its $11.3B portfolio in Q1 2026.
- Brevan Howard Capital Management opened 888 new positions and closed 479 in Q1 2026.
- Brevan Howard Capital Management's portfolio value rose 23% quarter-over-quarter to $11.3B.
Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.